DaVita
DVA
#1887
Rank
S$14.69 B
Marketcap
S$230.28
Share price
1.01%
Change (1 day)
30.25%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$14.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$14.02. In 2025 the company made an earnings per share (EPS) of S$12.90 a decrease over its 2024 EPS that were of S$14.06.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$14.109.34%
2025S$12.90-8.25%
2024S$14.0644.94%
2023S$9.7027.26%
2022S$7.62-35.56%
2021S$11.8344.1%
2020S$8.2119.7%
2019S$6.86540.48%
2018S$1.07-76.07%
2017S$4.47-19.31%
2016S$5.54242.52%
2015S$1.62-62.87%
2014S$4.3613.43%
2013S$3.848.45%
2012S$3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$30.98 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$14.48 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$24.71 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.64-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA